Shinda Biotech: Revenue in the first half of the year was 5.953 billion yuan, a year-on-year increase of 50.6%.

Shinda Biotech announced that its operating income in the first half of 2025 was 5.953 billion yuan, a year-on-year increase of 50.6%; the profit during the period was 834 million yuan, compared with a loss of 393 million yuan in the same period last year. Non-IFRS profit was 1.213 billion yuan, compared with a loss of 160 million yuan in the same period last year.